Young CW - Search Results

1

Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide.

Rigas JR, Tong WP, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: young cw. Cancer Res. 1992 Dec 1;52(23):6619-23. Cancer Res. 1992. PMID: 1423306 Clinical Trial.

2

Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.

Young CW, Fanucchi MP, Declan Walsh T, Baltzer L, Yaldaei S, Stevens YW, Gordon C, Tong W, Rifkind RA, Marks PA. Young CW, et al. Cancer Res. 1988 Dec 15;48(24 Pt 1):7304-9. Cancer Res. 1988. PMID: 3191501

3

Phase I trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer.

Kris MG, Kinahan JJ, Gralla RJ, Fanucchi MP, Wertheim MS, O'Connell JP, Marks LD, Williams L, Farag F, Young CW, et al. Kris MG, et al. Among authors: young cw. Cancer Res. 1988 Oct 1;48(19):5573-9. Cancer Res. 1988. PMID: 3416310 Clinical Trial.

4

Clinical pharmacology of all-trans retinoic acid.

Muindi JR, Young CW, Warrell RP Jr. Muindi JR, et al. Among authors: young cw. Leukemia. 1994;8 Suppl 3:S16-21. Leukemia. 1994. PMID: 7808019 Clinical Trial.

5

Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule.

Rigas JR, Francis PA, Miller VA, Tong WP, Roistacher N, Kris MG, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: young cw. Cancer Chemother Pharmacol. 1995;35(6):483-8. doi: 10.1007/BF00686832. Cancer Chemother Pharmacol. 1995. PMID: 7882456 Clinical Trial.

6

Elevated plasma lipid peroxide content correlates with rapid plasma clearance of all-trans-retinoic acid in patients with advanced cancer.

Muindi JF, Scher HI, Rigas JR, Warrell RP Jr, Young CW. Muindi JF, et al. Among authors: young cw. Cancer Res. 1994 Apr 15;54(8):2125-8. Cancer Res. 1994. PMID: 8174117

7

Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole.

Rigas JR, Francis PA, Muindi JR, Kris MG, Huselton C, DeGrazia F, Orazem JP, Young CW, Warrell RP Jr. Rigas JR, et al. Among authors: young cw. J Natl Cancer Inst. 1993 Dec 1;85(23):1921-6. doi: 10.1093/jnci/85.23.1921. J Natl Cancer Inst. 1993. PMID: 8230282 Clinical Trial.

8

Edatrexate, an antifolate with antitumor activity: a review.

Grant SC, Kris MG, Young CW, Sirotnak FM. Grant SC, et al. Among authors: young cw. Cancer Invest. 1993;11(1):36-45. doi: 10.3109/07357909309020259. Cancer Invest. 1993. PMID: 8422595 Review.

9

Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.

Muindi JR, Frankel SR, Huselton C, DeGrazia F, Garland WA, Young CW, Warrell RP Jr. Muindi JR, et al. Among authors: young cw. Cancer Res. 1992 Apr 15;52(8):2138-42. Cancer Res. 1992. PMID: 1559217

10

Dose-ranging antiemetic trial of high-dose oral metoclopramide.

Tyson LB, Gralla RJ, Kris MG, Young CW, Clark RA. Tyson LB, et al. Among authors: young cw. Am J Clin Oncol. 1989 Jun;12(3):239-43. doi: 10.1097/00000421-198906000-00012. Am J Clin Oncol. 1989. PMID: 2658539 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters